Objectives

By participating in this continuing education program, the attendee should be able to:

  • Describe the framework for IRB review
  • Identify 3 criteria an IRB must consider when determining if a study is approvable
  • Explain considerations that an IRB makes when evaluating risk/benefit ratio, minimization of risks and the composition of the informed consent document.
Faculty
Robert Baevsky MD, FACEP
Chair Baystate IRB Board
Associate Professor of Medicine
University of Massachusetts Medical School-Baystate
Physician
Baystate Medical Center 
 
Gerald Korona RPh
Vice Chair Baystate IRB Board 1 
 
Jennifer Pacheco MPH, CIM, CIP
Director Healthcare Research Compliance; Chief Research Compliance Officer 
 
Peter DePergola II, PhD, MTS
Director Clinical Ethics, Baystate Health
IRB Member Baystate IRB Board 1
 
Marypat Toye RN , MS, ACRN, CCRP, CPXP
Vice Chair Baystate IRB Board 2
 

Faculty Disclosure
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
 

Session date: 
Thursday, October 17, 2019 - 12:00pm to 1:00pm
Location: 
Baystate Medical Center
759 Chestnut Street
Chestnut 5
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.